Orense, Arlie Mae S.

HRN: 27-55-44  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/03/2025
CEFUROXIME 500MG (TAB)
09/03/2025
09/09/2025
ORAL
500mg
Q12
S/P RMLE
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines